Testing safety of BI 3814916 in healthy volunteers
This trial tests how safe and tolerable different doses of the study drug BI 3814916 are in healthy adults. It helps find the right dose for future studies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- Your body mass index (BMI) is between 18.5 and 30.
- You agree not to do intense exercise for 3 days before study visits.
- You avoid alcohol and soft drugs (like marijuana) for 2 days before visits.
- You are generally healthy without major medical conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how well different doses of a new drug (BI 3804379) are tolerated. It is for healthy people and for patients with MASH (a type of fatty liver disease) who have advanced liver scarring.
This study tests a new medicine (BI 3776528) in healthy men to see how well different doses are tolerated. It helps researchers find the safest dose before testing in people with a condition.
This study tests how a new medicine (BI 3034701) moves through the body in healthy men who have normal weight or are overweight. It helps find the right dose and understand how the medicine works.
This study tests how a new medicine, BI 3000202, is absorbed into the blood. It includes people with different levels of liver function (normal, mild, moderate, or severe) to see if liver problems affect how the medicine works.
This trial tests different doses of a new medicine in healthy Japanese people and those with obesity or overweight. It aims to see how well the body handles the drug and if it is safe.
This study tests a new drug called IBI3032 in healthy volunteers to see how safe it is and how the body processes it. If you are in good health, you may be able to join.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.